Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-07-15THAR3Rishi Nangalia Reports No Securities Ownership in Canton Strategic Holdings
This Form 3 filing reports that Rishi Nangalia, a director of Canton Strategic Holdings, Inc. (ticker: CNTN), has no securities ownership in the company as of July 13, 2026. The filing indicates that Nangalia, who is identified as a director but not an officer or 10% owner, reported zero securities holdings. The filing...
Micro CapBiotechnology
2026-07-15ANL3Ownership Filing for Adlai Nortye Ltd.MEDIUM
This filing details the ownership of Adlai Nortye Ltd. (ANL) as of March 18, 2026. Roger Sawhney, a director, reported indirect ownership of 4000 American Depositary Shares (ADS) through Restricted Share Units (RSUs) with an exercise date of March 22, 2027. These RSUs are held by ESOP (Nortye International Limited) and...
Small CapBiotechnology
2026-07-15FULC3Ownership Filing for Fulcrum Therapeutics, Inc.MEDIUM
This filing reports on the beneficial ownership of Fulcrum Therapeutics, Inc. (FULC) as of July 13, 2026. The shares are beneficially owned by Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc. Kevin Tang, through his management of Tan...
Micro CapBiotechnology
2026-07-15Fulcrum Therapeutics, Inc.3Ownership Filing for Fulcrum Therapeutics, Inc.DuplicateMEDIUM
This filing reports on the beneficial ownership of Fulcrum Therapeutics, Inc. (FULC) as of July 13, 2026. The shares are beneficially owned by Tang Capital Partners, LP, Tang Capital Partners International, LP, Tang Capital Partners III, Inc., and Tang Capital Partners IV, Inc. Kevin Tang, through his management of Tan...
Micro CapBiotechnology